Cellectis bioresearch, the specialist in genome customization and subsidiary of Cellectis , and Helix BioService & Consultants Pvt Ltd (Helix Biocon), announced that they will join forces for the promotion of Cellectis bioresearch’s meganuclease-based products and services in India.
Helix Biocon is a young company comprised of professionals with proven expertise in the field of Life sciences, pharmaceuticals and drug discovery research. The companies will pool their expertise to ensure maximum availability for the innovative cellular Genome Positioning System (cGPS) lines of products and to promote cell line engineering service for bioproduction.
“Cellectis bioresearch aims to make its products the gold standard in genome customization for the life science community throughout the world,” said Luc Selig, VP sales & marketing at Cellectis bioresearch. “India, as a major player in bioproduction, is a key market for our cell line engineering services. This new collaboration with Helix Biocon will bring our full line of products and services to the growing Indian science community.”
Cellectis bioresearch’s portfolio today offers over 100 product references, addressing the major needs for genome customization of the life science community.
“We believe Cellectis bioresearch has exciting product lines for top level researchers in pharmaceutical, drug discovery and academia and is poised to redefine genome engineering,” said R Agarwal, business director of Helix Biocon. “By providing the cGPS lines of products coupled with Cellectis’ technology transfer and partnership services, Helix Biocon shall be able to offer game changing tools to our Indian customers to assist them in the pursuit of tomorrow’s most important scientific discoveries.”
Cellectis bioresearch was incorporated as a subsidiary of Cellectis in June 2008. It provides life science researchers with ready- and easy-to-use tools for genome customization. These tools, based on meganucleases, enable the engineering of cells with optimized features for drug discovery, protein production and gene functional studies.
Cellectis is a pioneer in the field of genome engineering. The company designs and markets innovative tools -meganucleases. These molecular scissors enable targeted modifications to DNA, with applications in the research, biomanufacturing, agrobiotechnology and therapeutic sectors.
Helix BioService & Consultants Pvt. Ltd, New Delhi, India, professionally managed by a young team which has rich experience in the field of academia, drug discovery and pharmaceutical Research, (Instrumentation, Software, Reagents and Services), and other technologies with a vision to expand into new areas of Healthcare.